EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry

Valentina Lahn iD, Sascha R Tittel iD, Ute Ohlenschläger iD, Clemens Kamrath iD, Johanna Hammersen iD, Renata Gellai iD, Kirsten Mönkemöller iD, Axel Dost iD, Heike Bartelt iD, Reinhard W Holl iD

Pediatric Diabetes · 2025

DOI: 10.1155/pedi/9903467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Diabetes, 2025. Verfasst von Valentina Lahn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Altona Children's Hospital, Hamburg, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate whether the remission period in type 1 diabetes, as measured by insulin‐dose adjusted A1c (IDAA1C), was affected by the COVID‐19 pandemic. Data from 7603 children and adolescents with type 1 diabetes from the prospective diabetes follow‐up (DPV) registry were available. We compared two time periods of diabetes onset, 2020/2021 vs. 2018/2019. IDAA1C and remission prevalence (IDAA1c < 9%) were analyzed using logistic and linear regression models adjusted for age groups (0.5–

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1COVID-19HumansChildMaleRegistriesAdolescentFemaleRemission InductionChild, PreschoolInfantInsulinGlycated HemoglobinProspective StudiesHypoglycemic AgentsDiabetic KetoacidosisSARS-CoV-2Insulin Infusion Systems

Substanzen

InsulinGlycated HemoglobinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Altona Children's Hospital, Hamburg, Germany.
  • Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
  • German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
  • Center of Children and Adolescent, Friedrich-Ebert-Hospital, Neumuenster, Germany.
  • Center of Child and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.

ORCID-Profile: Valentina Lahn, Sascha R Tittel, Ute Ohlenschläger, Clemens Kamrath, Johanna Hammersen, Renata Gellai, Kirsten Mönkemöller, Axel Dost, Heike Bartelt, Reinhard W Holl

Zitieren

APA

Lahn, V., Tittel, S. R., Ohlenschläger, U., Kamrath, C., Hammersen, J., Gellai, R., Mönkemöller, K., Dost, A., Bartelt, H., & Holl, R. W. (2025). Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry. Pediatric Diabetes. https://doi.org/10.1155/pedi/9903467

Vancouver

Lahn V, Tittel SR, Ohlenschläger U, Kamrath C, Hammersen J, Gellai R, et al. Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry. Pediatric Diabetes. 2025. doi:10.1155/pedi/9903467

BibTeX
@article{Lahn2025,
  author = {Lahn, Valentina and Tittel, Sascha R and Ohlenschläger, Ute and Kamrath, Clemens and Hammersen, Johanna and Gellai, Renata and Mönkemöller, Kirsten and Dost, Axel and Bartelt, Heike and Holl, Reinhard W},
  title = {Remission Period in Children With Newly Diagnosed Type 1 Diabetes During the COVID‐19 Pandemic‐Results From the DPV Registry},
  journal = {Pediatric Diabetes},
  year = {2025},
  doi = {10.1155/pedi/9903467}
}
Kostenlos starten →